{"id":"W4416380369","doi":"10.1016/j.ejca.2025.116110","title":"Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Astellas Pharma; Astellas Pharma US; Pfizer","keywords":"Enzalutamide; Post-hoc analysis; Post hoc; Subgroup analysis; Recurrent prostate cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004603129,0.001340424,0.003037291,0.0003292465,0.0002292263,0.0008722404,0.0007450631,0.0005850412,0.004563698],"category_scores_gemma":[0.002378148,0.000322921,0.0044308,0.0004296926,0.0004501416,0.0007609839,0.0004629378,0.001422847,0.0004211991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006296565,"about_ca_system_score_gemma":0.000925985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008934759,"about_ca_topic_score_gemma":0.001759595,"domain_scores_codex":[0.997829,0.001474144,0.0001317677,0.0002564811,0.000112669,0.0001959225],"domain_scores_gemma":[0.9981734,0.0008604565,0.0004054254,0.0002032067,0.0001169149,0.0002406103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.985981,0.0008382683,0.003104354,0.0002306564,0.003778388,0.00003021283,0.00001780068,0.0005489681,0.0009386544,0.00003163205,0.000352127,0.004147938],"study_design_scores_gemma":[0.6309052,0.2759493,0.06205743,0.0001118525,0.02026488,0.0001536456,0.00009594005,0.004234198,0.002900831,0.0004091934,0.00284482,0.00007265455],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924155,0.003338819,0.0005755794,0.0002179716,0.000153012,0.0006265998,0.001369717,0.00005618275,0.001246569],"genre_scores_gemma":[0.9939174,0.0008355466,0.0006680571,0.0002751904,0.0001599026,0.0009212957,0.001463518,0.00002861723,0.001730404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004603129,"threshold_uncertainty_score":0.02434397,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007018902896745158,"score_gpt":0.2850381728637095,"score_spread":0.2780192699669644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}